"This is changing the way we practice prostate cancer." ...

This is a rare opportunity for me personally, this is my only hope to extend my life by any real period at all." ...

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

The 2026 European Association of Urology (EAU) annual meeting featured an advancing prognostics and therapeutics in ...

If you or a loved one has been diagnosed with prostate cancer, you’re not alone—and you don’t have to wait long to take the next step. Whether you’re newly diagnosed, moving from active surveillance ...

Despite several randomized controlled trials demonstrating the benefits of combination therapies for metastatic hormone-sensitive prostate cancer (mHSPC), a significant treatment gap persists. This ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...